Morepen Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morepen Laboratories Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.40 billion Indian Rupees [US$83.20 million]
of which 96%
Neuland Laboratories Limited
(5.73 billion Indian Rupees [US$88.32 million]
of which 100%
was Bulk Drugs), and
Suven Life Sciences Limited
(5.44 billion Indian Rupees [US$83.81 million]
of which 95%
was Intermediaries under Contract Research/M).
Morepen Laboratories Limited reported sales of 5.84 billion Indian Rupees (US$90.04 million)
March of 2017.
increase of 20.4%
versus 2016, when the company's sales were 4.85 billion Indian Rupees.
Sales at Morepen Laboratories Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 108%).